Literature DB >> 18008315

Relevance of measuring diastolic time intervals in the ductus venosus during the early stages of twin-twin transfusion syndrome.

B Bensouda1, J-C Fouron, M-J Raboisson, J Lamoureux, C Lachance, L Leduc.   

Abstract

OBJECTIVE: To determine if the discrete myocardial diastolic dysfunction documented previously in the recipient twin during the early stages of twin-twin transfusion syndrome (TTTS) has any repercussion on flow velocities through the ductus venosus (DV) and to investigate if this could allow early differentiation between TTTS and selective intrauterine growth restriction (IUGR).
METHODS: Two groups of monochorionic twin pregnancies with growth discordance between twins were reviewed retrospectively. Group I was composed of fetuses in Stages I and II of TTTS; laser or amnioreduction was not performed in any instance. Group II twin pairs each included one fetus with IUGR due to placental circulatory insufficiency. Intertwin differences (smaller minus larger fetus) were analyzed for myocardial performance index of the right ventricle (MPI-RV) and for time variables in the DV.
RESULTS: There were 38 pairs of monochorionic twins (24 TTTS and 14 IUGR) in this study. In the TTTS group, the donors had a significantly lower MPI-RV (0.419 +/- 0.18 vs. 0.596 +/- 0.17, F(1,19df) = 24.017, P < 0.001), a significantly longer total ventricular filling time (150.9 +/- 25.6 ms vs. 124.0 +/- 22.6 ms; F(1,21df) = 19.631, P < 0.001) and a significantly longer early filling time (118.9 +/- 22.9 ms vs. 92.6 +/- 18.9 ms, F(1,21df) = 28.419, P < 0.001) than had the recipient. None of these three differences was present in the IUGR group. Probability studies revealed that cut-off values of 12.75 for intertwin differences in total filling time and 8.5 for intertwin differences in early filling time had sensitivities of 71% and 92%, respectively. The false-positive rates were 23% and 15%, respectively, for the early diagnosis of TTTS.
CONCLUSION: In monochorionic twin pregnancies, shortening of the ventricular filling time in the recipient twin indicates diastolic myocardial dysfunction occurring early in the pathophysiology of TTTS. This early interwin difference in myocardial function is not found in pregnancies with IUGR in one twin due to placental circulatory insufficiency, allowing early differentiation between TTTS and selective IUGR.

Entities:  

Mesh:

Year:  2007        PMID: 18008315     DOI: 10.1002/uog.5161

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  5 in total

1.  Diastolic Cardiac Pathology and Clinical Twin-Twin Transfusion Syndrome in Monochorionic/Diamniotic Twins.

Authors:  Anita J Moon-Grady; Larry Rand; Salvador Gallardo; Kristen Gosnell; Hanmin Lee; Vickie A Feldstein
Journal:  Am J Obstet Gynecol       Date:  2011-09-01       Impact factor: 8.661

2.  The Fetal Heart in Twin-to-Twin Transfusion Syndrome.

Authors:  Tim Van Mieghem; Liesbeth Lewi; Léonardo Gucciardo; Philip Dekoninck; Dominique Van Schoubroeck; Roland Devlieger; Jan Deprest
Journal:  Int J Pediatr       Date:  2010-08-08

Review 3.  Fetal cardiovascular alterations in twin-to-twin transfusion syndrome.

Authors:  Ioana Cristina Rotar; Gabriela Zaharie; Adelina Staicu; Andreia Preda; Daniel Mureşan
Journal:  Med Pharm Rep       Date:  2020-01-31

4.  Fetal ventricular strain in uncomplicated and selective growth-restricted monochorionic diamniotic twin pregnancies and cardiovascular response in pre-twin-twin transfusion syndrome.

Authors:  C Wohlmuth; A Agarwal; B Stevens; A Johnson; K J Moise; R Papanna; R Donepudi; C S Bell; I E Averiss; H M Gardiner
Journal:  Ultrasound Obstet Gynecol       Date:  2020-11       Impact factor: 7.299

5.  Reference values for fetal Doppler-based cardiocirculatory indices in monochorionic-diamniotic twin pregnancy.

Authors:  Thananan Chongsomboonsuk; Nisarat Phithakwatchara; Katika Nawapun; Sommai Viboonchart; Suparat Jaingam; Tuangsit Wataganara
Journal:  BMC Pregnancy Childbirth       Date:  2021-11-30       Impact factor: 3.007

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.